Human papillomavirus type 16 does not require cathepsin L or B for infection

Journal of General Virology

Volumn 94, Issue PART8, 2013, Pages 1865-1869

  Calton, Christine M ^a,b   Schlegel, Angela M ^a,c   Chapman, Janice A ^a,b   Campos, Samuel K ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN L; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; EMBRYO CELL; FIBROBLAST; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL;

ANIMALS; CATHEPSIN B; CATHEPSIN L; CELL LINE; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICE; MICE, KNOCKOUT; VIRUS INTERNALIZATION;

EID: 84880162667     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.053694-0     Document Type: Article

References (16)

1. Akache, B., Grimm, D., Shen, X., Fuess, S., Yant, S. R., Glazer, D. S., Park, J. & Kay, M. A. (2007). A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8. Mol Ther 15, 330-339.
2. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A. & Fusenig, N. E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106, 761-771.
3. Campos, S. K., Chapman, J. A., Deymier, M. J., Bronnimann, M. P. & Ozbun, M. A. (2012). Opposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetration. J Virol 86, 4169-4181.
4. Conus, S. & Simon, H. U. (2010). Cathepsins and their involvement in immune responses. Swiss Med Wkly 140, w13042.
5. Dabydeen, S. A. & Meneses, P. I. (2009). The role of NH4Cl and cysteine proteases in Human Papillomavirus type 16 infection. Virol J 6, 109.
6. Day, P. M., Baker, C. C., Lowy, D. R. & Schiller, J. T. (2004). Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A 101, 14252-14257.
7. Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H. L. & Villadangos, J. A. (1998). Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci U S A 95, 4516-4521.
8. Ebert, D. H., Deussing, J., Peters, C. & Dermody, T. S. (2002). Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem 277, 24609-24617.
9. Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., LortetTieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F. & other authors (2012). Global burden of human papillomavirus and related diseases. Vaccine 30 (Suppl 5), F12-F23.
10. Kaletsky, R. L., Simmons, G. & Bates, P. (2007). Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 81, 13378-13384.
11. Misasi, J., Chandran, K., Yang, J. Y., Considine, B., Filone, C. M., Côté, M., Sullivan, N., Fabozzi, G., Hensley, L. & Cunningham, J. (2012). Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J Virol 86, 3284-3292.
12. Schelhaas, M., Shah, B., Holzer, M., Blattmann, P., Kuhling, L., Day, P. M., Schiller, J. T. & Helenius, A. (2012). Entry of human papillomavirus type 16 by actin-dependent, clathrinand lipid raftindependent endocytosis. PLoS Pathog 8, e1002657.
13. Smith, J. L., Campos, S. K., Wandinger-Ness, A. & Ozbun, M. A. (2008). Caveolin-1-dependent infectious entry of human papilloma virus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. J Virol 82, 9505-9512.
14. Turk, V., Stoka, V., Vasiljeva, O., Renko, M., Sun, T., Turk, B. & Turk, D. (2012). Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim Biophys Acta 1824, 68-88.
15. Woodman, C. B., Collins, S. I. & Young, L. S. (2007). The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7, 11-22.
16. zur Hausen, H. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2, 342-350.